Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis.
Rheumatology (Oxford)
; 2023 Nov 22.
Article
in En
| MEDLINE
| ID: mdl-37991871
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Rheumatology (Oxford)
Journal subject:
REUMATOLOGIA
Year:
2023
Type:
Article
Affiliation country:
Italy